Australia markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
125.00-0.59 (-0.47%)
At close: 04:00PM EDT
125.36 +0.36 (+0.29%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 47.90B
Enterprise value 40.62B
Trailing P/E 7.06
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.37
Price/book (mrq)3.74
Enterprise value/revenue 7.99
Enterprise value/EBITDA -9.70

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-4.68%
S&P500 52-week change 322.38%
52-week high 3142.79
52-week low 362.55
50-day moving average 3104.33
200-day moving average 398.44

Share statistics

Avg vol (3-month) 33.92M
Avg vol (10-day) 33.83M
Shares outstanding 5383.24M
Implied shares outstanding 6384.81M
Float 8344.85M
% held by insiders 19.61%
% held by institutions 173.40%
Shares short (15 Apr 2024) 420.98M
Short ratio (15 Apr 2024) 45.88
Short % of float (15 Apr 2024) 47.22%
Short % of shares outstanding (15 Apr 2024) 45.48%
Shares short (prior month 15 Mar 2024) 422.23M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -115.82%
Operating margin (ttm)-758.08%

Management effectiveness

Return on assets (ttm)-15.72%
Return on equity (ttm)-37.68%

Income statement

Revenue (ttm)5.15B
Revenue per share (ttm)13.52
Quarterly revenue growth (yoy)-91.00%
Gross profit (ttm)N/A
EBITDA -4.56B
Net income avi to common (ttm)-5.97B
Diluted EPS (ttm)-15.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.52B
Total cash per share (mrq)22.31
Total debt (mrq)1.21B
Total debt/equity (mrq)9.46%
Current ratio (mrq)4.03
Book value per share (mrq)33.55

Cash flow statement

Operating cash flow (ttm)-2.88B
Levered free cash flow (ttm)-1.96B